EP2579877
Morfólínópýrimídín og notkun þeirra í meðferð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.6.2011EP published:
13.8.2014EP application number:
11725494.6
EP translation filed:
1.10.2014Grant published:
15.10.2014EPO information:
European Patent Register
Max expiry date:
8.6.2031Expiry date:
8.6.2026Next due date:
30.6.2026
Title:
MORPHOLINO PYRIMIDINES AND THEIR USE IN THERAPY
Timeline
Today
9.6.2011EP application
13.8.2014EP Publication
1.10.2014Translation submitted
15.10.2014Registration published
8.6.2026Expires
Owner
Name:
AstraZeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
FOOTE, Kevin, MichaelAddress:
Macclesfield, Cheshire SK10 4TG, GB
Name:
NISSINK, Johannes, Wilhelmus, MariaAddress:
Macclesfield, Cheshire SK10 4TG, GB
Name:
TURNER, PaulAddress:
Macclesfield, Cheshire SK10 4TG, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
353713 PDate:
11.6.2010Country:
US
Classification
Categories:
A61K 31/505, C07D 413/14, C07D 471/04, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 7.5.2015
Expires: 8.6.2016
Payer: Árnason Faktor
Number: 6
Paid: 10.5.2016
Expires: 8.6.2017
Payer: Árnason Faktor
Number: 7
Paid: 8.5.2017
Expires: 8.6.2018
Payer: Árnason Faktor
Number: 8
Paid: 14.5.2018
Expires: 8.6.2019
Payer: Árnason Faktor
Number: 9
Paid: 8.5.2019
Expires: 8.6.2020
Payer: Árnason Faktor
Number: 10
Paid: 5.5.2020
Expires: 8.6.2021
Payer: Árnason Faktor ehf.
Number: 11
Paid: 11.5.2021
Expires: 8.6.2022
Payer: Árnason Faktor ehf.
Number: 12
Paid: 6.5.2022
Expires: 8.6.2023
Payer: Árnason Faktor ehf.
Number: 13
Paid: 24.5.2023
Expires: 8.6.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 7.5.2024
Expires: 8.6.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 2.6.2025
Expires: 8.6.2026
Payer: Árnason Faktor ehf.